Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors.
暂无分享,去创建一个
A Sette | J Sidney | J. Sidney | A. Sette | D. Accapezzato | V. Barnaba | S. Abrignani | P. Scognamiglio | S. Southwood | M. Casciaro | S Southwood | M. Artini | V Barnaba | S Abrignani | M Artini | P Scognamiglio | D Accapezzato | M A Casciaro | A Cacciani | G Bruno | M L Chircu | A. Cacciani | G. Bruno | M. L. Chircu | Marco Antonio Casciaro | Maria Lucia Chircu
[1] B. Walker,et al. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. , 1995, The Journal of clinical investigation.
[2] F. Chisari,et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.
[3] M. Bevan,et al. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. , 1998, Immunity.
[4] P. Doherty,et al. Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia , 1994, Journal of virology.
[5] M F del Guercio,et al. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. , 1996, Human immunology.
[6] J. Altman,et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.
[7] A. McMichael,et al. Rapid Effector Function in CD8+ Memory T Cells , 1997, The Journal of experimental medicine.
[8] B. Walker,et al. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. , 1998, Journal of immunology.
[9] D. Krüger,et al. Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin , 1995, The Lancet.
[10] M. Houghton,et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.
[11] R. Zinkernagel,et al. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[12] V. Barnaba,et al. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus. , 1994, Journal of immunology.
[14] J. Berzofsky,et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. , 1992, The Journal of infectious diseases.
[15] M F del Guercio,et al. Several HLA alleles share overlapping peptide specificities. , 1995, Journal of immunology.
[16] David Gray,et al. Immunological Memory and Protective Immunity: Understanding Their Relation , 1996, Science.
[17] C Crimi,et al. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome. , 1996, International immunology.
[18] J. Sidney,et al. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules , 1993, Cell.
[19] L. Moretta,et al. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers. , 1994, The Journal of infectious diseases.
[20] R W Chesnut,et al. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. , 1997, The Journal of clinical investigation.
[21] S. Rowland-Jones,et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women , 1995, Nature Medicine.
[22] N. Tinari,et al. Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients. , 1996, Journal of hepatology.
[23] M. Houghton,et al. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. , 1990, British medical bulletin.
[24] B. Malissen,et al. Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. , 2008, Tissue antigens.
[25] J. Sprent,et al. Immunological Memory , 1990, Current Topics in Microbiology and Immunology.
[26] M. Merkenschlager,et al. Memory T cells , 1989, Nature.
[27] M F del Guercio,et al. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. , 1996, Journal of immunology.
[28] M. Rep,et al. Phenotypic and Functional Separation of Memory and Effector Human CD8+ T Cells , 1997, The Journal of experimental medicine.
[29] D. Vlahov,et al. Correlates of Hepatitis C Virus Infections among Injection Drug Users , 1995, Medicine.
[30] Transmission of Hepatitis C Virus from Mothers to Infants , 1994 .
[31] R M Zinkernagel,et al. Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies [corrected]. , 1996, Nature.
[32] M. Clerici,et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals , 1997, Nature Medicine.
[33] H. Ohto,et al. Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. , 1994, The New England journal of medicine.
[34] M. Onji,et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[35] M. Clerici,et al. T‐cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques , 1994, AIDS.
[36] B. Walker,et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. , 1992, Journal of immunology.
[37] S. Rowland-Jones,et al. Immune responses in HIV-exposed seronegatives: have they repelled the virus? , 1995, Current opinion in immunology.
[38] G. Ogg,et al. Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo , 1998, The Journal of experimental medicine.
[39] J. Bronowicki,et al. Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients. , 1997, The Journal of infectious diseases.
[40] M. Longobardi,et al. Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro. , 1995, International immunology.
[41] F. Chisari,et al. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. , 1996, The Journal of clinical investigation.
[42] C. Barnstable,et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.
[43] B. Walker,et al. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. , 1997, The Journal of infectious diseases.
[44] B. Walker,et al. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV , 1993, Journal of virology.
[45] M A Nowak,et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.
[46] A. McMichael,et al. Rapid Effector Function in CD 8 1 Memory T Cells , 1997 .
[47] V. Barnaba,et al. Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. , 1989, Journal of immunology.
[48] H. Hengartner,et al. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. , 1996, Current opinion in immunology.
[49] S. Nagata,et al. The Fas death factor , 1995, Science.
[50] R. Zinkernagel,et al. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. , 1996, Annual review of immunology.
[51] H. Bielefeldt-Ohmann,et al. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. , 1992, Science.
[52] R W Chesnut,et al. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. , 1997, Immunity.
[53] R. Zinkernagel,et al. Specific cytotoxic T cells eliminate cells producing neutralizing antibodies , 1996, Nature.
[54] H. Pircher,et al. On T Cell Memory: Arguments for Antigen Dependence , 1996, Immunological reviews.
[55] M. Esteban,et al. Quantification of antigen specific CD8+ T cells using an ELISPOT assay. , 1995, Journal of immunological methods.
[56] J. Sidney,et al. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. , 1994, Molecular immunology.
[57] M. Houghton,et al. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. , 1993, Journal of immunology.
[58] V. Barnaba,et al. Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes , 1990, Nature.
[59] G Hermanson,et al. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. , 1995, Journal of immunology.
[60] H. Grey,et al. Structural analysis of peptides capable of binding to more than one Ia antigen. , 1989, Journal of immunology.
[61] L. Hsiao,et al. A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. , 1997, Journal of immunological methods.